Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Lung cancer is the leading cause of cancer-related deaths worldwide. Despite growing efforts for its early detection by screening populations at risk, the majority of lung cancer patients are still diagnosed in an advanced stage. The management of lung cancer has dramatically improved in the last de...
Guardado en:
Autores principales: | Maja Šutić, Ana Vukić, Jurica Baranašić, Asta Försti, Feđa Džubur, Miroslav Samaržija, Marko Jakopović, Luka Brčić, Jelena Knežević |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/00f9bdc3beec41cc9b5219b955f161b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
por: Zhang Zhihui, et al.
Publicado: (2021) -
Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
por: Jian He, et al.
Publicado: (2021) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Guojun Lu, et al.
Publicado: (2021) -
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
por: Qunhao Zheng, et al.
Publicado: (2021) -
Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis
por: Dong Q, et al.
Publicado: (2021)